These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 10571520)

  • 1. Utility of immunohistochemistry in the evaluation of necrotic thyroid tumors.
    Judkins AR; Roberts SA; Livolsi VA
    Hum Pathol; 1999 Nov; 30(11):1373-6. PubMed ID: 10571520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thyroid transcription factor-1, thyroglobulin, cytokeratin 7, and cytokeratin 20 in thyroid neoplasms.
    Bejarano PA; Nikiforov YE; Swenson ES; Biddinger PW
    Appl Immunohistochem Mol Morphol; 2000 Sep; 8(3):189-94. PubMed ID: 10981870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensitivity and specificity of antibodies on necrotic tumor tissue.
    Judkins AR; Montone KT; LiVolsi VA; van de Rijn M
    Am J Clin Pathol; 1998 Nov; 110(5):641-6. PubMed ID: 9802350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced HBME-1 immunoreactivity of papillary thyroid carcinoma and papillary thyroid carcinoma-related neoplastic lesions with Hürthle cell and/or apocrine-like changes.
    Mai KT; Bokhary R; Yazdi HM; Thomas J; Commons AS
    Histopathology; 2002 Feb; 40(2):133-42. PubMed ID: 11952857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis of necrotic and degenerate thyroid lesions: value of immunohistochemistry.
    Chai SM; Kumarasinghe MP
    Histopathology; 2011 Sep; 59(3):496-503. PubMed ID: 22034889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical detection of thyroid transcription factor-1, thyroglobulin, and calcitonin in canine normal, hyperplastic, and neoplastic thyroid gland.
    Ramos-Vara JA; Miller MA; Johnson GC; Pace LW
    Vet Pathol; 2002 Jul; 39(4):480-7. PubMed ID: 12126151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retinoblastoma expression in thyroid neoplasms.
    Anwar F; Emond MJ; Schmidt RA; Hwang HC; Bronner MP
    Mod Pathol; 2000 May; 13(5):562-9. PubMed ID: 10824929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The RET/PTC oncogene is frequently activated in oncocytic thyroid tumors (Hurthle cell adenomas and carcinomas), but not in oncocytic hyperplastic lesions.
    Chiappetta G; Toti P; Cetta F; Giuliano A; Pentimalli F; Amendola I; Lazzi S; Monaco M; Mazzuchelli L; Tosi P; Santoro M; Fusco A
    J Clin Endocrinol Metab; 2002 Jan; 87(1):364-9. PubMed ID: 11788677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does Hurthle cell lesion/neoplasm predict malignancy more than follicular lesion/neoplasm on thyroid fine-needle aspiration?
    Pu RT; Yang J; Wasserman PG; Bhuiya T; Griffith KA; Michael CW
    Diagn Cytopathol; 2006 May; 34(5):330-4. PubMed ID: 16604553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of specific patterns on the sensitivity for follicular and Hurthle cell carcinoma in thyroid fine-needle aspiration.
    Renshaw AA; Gould EW
    Cancer Cytopathol; 2016 Oct; 124(10):729-736. PubMed ID: 27322887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical analysis of thyroid adenomas with Hurthle cells.
    Kanthan R; Radhi JM
    Pathology; 1998 Feb; 30(1):4-6. PubMed ID: 9534199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Thyroidal oxyphilic tumors].
    Sabo R; Zohar Y; Schwartz A; Segal K
    Harefuah; 1994 Feb; 126(4):183-6, 240. PubMed ID: 8168757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An immunohistochemical study of thyroid Hurthle cells and their neoplasms: the roles of S-100 and HMB-45 proteins.
    Abu-Alfa AK; Straus FH; Montag AG
    Mod Pathol; 1994 Jun; 7(5):529-32. PubMed ID: 7937716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CITED1 protein expression suggests Papillary Thyroid Carcinoma in high throughput tissue microarray-based study.
    Prasad ML; Pellegata NS; Kloos RT; Barbacioru C; Huang Y; de la Chapelle A
    Thyroid; 2004 Mar; 14(3):169-75. PubMed ID: 15072698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variable expression of keratins and nearly uniform lack of thyroid transcription factor 1 in thyroid anaplastic carcinoma.
    Miettinen M; Franssila KO
    Hum Pathol; 2000 Sep; 31(9):1139-45. PubMed ID: 11014583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fine-needle aspiration biopsy of papillary thyroid carcinoma: diagnostic utility of cytokeratin 19 immunostaining.
    Nasser SM; Pitman MB; Pilch BZ; Faquin WC
    Cancer; 2000 Oct; 90(5):307-11. PubMed ID: 11038428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Keratin subsets in papillary and follicular thyroid lesions. A paraffin section analysis with diagnostic implications.
    Miettinen M; Kovatich AJ; Kärkkäinen P
    Virchows Arch; 1997 Dec; 431(6):407-13. PubMed ID: 9428928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CA125 and thyroglobulin staining in papillary carcinomas of thyroid and ovarian origin is not completely specific for site of origin.
    Keen CE; Szakacs S; Okon E; Rubin JS; Bryant BM
    Histopathology; 1999 Feb; 34(2):113-7. PubMed ID: 10064389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peroxisome proliferator activated receptor gamma immunohistochemical expression in human papillary thyroid carcinoma tissues. Possible relationship to lymph node metastasis.
    Galusca B; Dumollard JM; Chambonniere ML; Germain N; Prades JM; Péoc'h M; Estour B
    Anticancer Res; 2004; 24(3b):1993-7. PubMed ID: 15274390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thyroglobulin and calcitonin immunoreactivity in canine thyroid carcinomas.
    Moore FM; Kledzik GS; Wolfe HJ; DeLellis RA
    Vet Pathol; 1984 Mar; 21(2):168-73. PubMed ID: 6375099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.